Evan Loh Insider Trading $EIGR Eiger BioPharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Evan Loh.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Evan Loh. Evan Loh is Director in WINDTREE THERAPEUTICS INC /DE/ ($WINT) and CEO in Paratek Pharmaceuticals, Inc. ($PRTK) and President and CMO in Paratek Pharmaceuticals, Inc. ($PRTK) and President, COO and CMO in Paratek Pharmaceuticals, Inc. ($PRTK) and See Remarks in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in Eiger BioPharmaceuticals, Inc. ($EIGR) and Director in Nivalis Therapeutics, Inc. ($NVLS).
Evan Loh in Eiger BioPharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Evan Loh: Director
Holdings: 10,000 shares
Current Value: $116,000
Latest Transaction: Mar 15 2021
$EIGR Market Capitalization: $93.59M
$EIGR Previous Close: $11.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Evan Loh in Eiger BioPharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, EIGR, PRTK, WINT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Loh Evan | Director | Option Exercise | A | 9.99 | 10,000 | 99,900 | 10,000 | |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Loh Evan | Director | Sell | S | 10.14 | 2,000 | 20,280 | 8,000 | 10 K to 8 K (-20.00 %) |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Loh Evan | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| Mar 13 2020 | EIGR | Eiger BioPharmaceu ... | Loh Evan | Director | Option Exercise | A | 5.60 | 10,000 | 56,000 | 10,000 | |
| Mar 13 2020 | EIGR | Eiger BioPharmaceu ... | Loh Evan | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Loh Evan | Director | Option Exercise | A | 14.31 | 10,000 | 143,100 | 10,000 | |
| Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Loh Evan | Director | Option Exercise | A | 14.31 | 10,000 | 143,100 | 10,000 | |
| Mar 16 2018 | EIGR | Eiger BioPharmaceu ... | Loh Evan | Director | Option Exercise | A | 9.50 | 10,000 | 95,000 | 10,000 | |
| Sep 18 2017 | EIGR | Eiger BioPharmaceu ... | Loh Evan | Director | Option Exercise | A | 11.15 | 25,000 | 278,750 | 25,000 |
Page: 1